A Study in Healthy Men That Tests if Taking BI 1265162 by Mouth, Intravenously, or Inhaled Influences the Amount of BI 1265162 in the Blood
Clinical trial NCT03907280 · COMPLETED
Trial details
- NCT number
- NCT03907280
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-23
- Primary completion
- 2019-12-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.